Related Experiment Video
Updated: Feb 26, 2026

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition
Published on: October 9, 2014
The emerging role of alternative splicing in senescence and aging
Mathieu Deschênes1, Benoit Chabot1
1Department of Microbiology and Infectious Diseases, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke, Quebec, J1E 4K8, Canada.
Abstract:
Deregulation of precursor mRNA splicing is associated with many illnesses and has been linked to age-related chronic diseases. Here we review recent progress documenting how defects in the machinery that performs intron removal and controls splice site selection contribute to cellular senescence and organismal aging. We discuss the functional association linking p53, IGF-1, SIRT1, and ING-1 splice variants with senescence and aging, and review a selection of splicing defects occurring in accelerated aging (progeria), vascular aging, and Alzheimer's disease. Overall, it is becoming increasingly clear that changes in the activity of splicing factors and in the production of key splice variants can impact cellular senescence and the aging phenotype.
Insights
Splicing defects in precursor mRNA impact cellular senescence and organismal aging. These changes in splicing factors and splice variants are linked to age-related diseases and the aging process.
Area of Science:
- Molecular Biology
- Genetics
- Gerontology
Background:
- Deregulation of precursor mRNA splicing is implicated in various illnesses.
- Splicing machinery defects are linked to age-related chronic diseases, cellular senescence, and organismal aging.
Purpose of the Study:
- To review recent advancements in understanding the role of splicing defects in aging.
- To discuss the functional links between specific splice variants and senescence/aging.
- To examine splicing defects in conditions like progeria, vascular aging, and Alzheimer's disease.
Main Methods:
- Literature review of recent progress in splicing research related to aging.
- Discussion of functional associations between splice variants (p53, IGF-1, SIRT1, ING-1) and senescence.
- Review of splicing defects in specific age-related pathologies.
Main Results:
- Defects in intron removal and splice site selection machinery contribute to cellular senescence and aging.
- Specific splice variants of p53, IGF-1, SIRT1, and ING-1 are functionally associated with senescence and aging.
- Splicing defects are observed in accelerated aging (progeria), vascular aging, and Alzheimer's disease.
Conclusions:
- Changes in splicing factor activity and splice variant production significantly impact cellular senescence.
- Altered splicing contributes to the overall aging phenotype.
- Splicing deregulation is a key factor in age-related cellular dysfunction and disease.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Pre-mRNA Processing: RNA Splicing
What is Gene Expression?

